NON-SPECIFIC VULVITIS.
BAKER HW.
J Ky Med Assoc. 1965 Feb;63:101-2.
Vulvovaginitis in childhood.
Dei M, Di Maggio F, Di Paolo G, Bruni V.
Best Pract Res Clin Obstet Gynaecol. 2010 Apr;24(2):129-37. doi: 10.1016/j.bpobgyn.2009.09.010. Epub 2009 Nov 1.
Vulvovaginitis- presentation of more common problems in pediatric and adolescent gynecology.
Loveless M, Myint O.
Best Pract Res Clin Obstet Gynaecol. 2018 Apr;48:14-27. doi: 10.1016/j.bpobgyn.2017.08.014. Epub 2017 Sep 5.
Immune responses to fungal infections and therapeutic implications.
Altamura M, Casale D, Pepe M, Tafaro A.
Curr Drug Targets Immune Endocr Metabol Disord. 2001 Nov;1(3):189-97. doi: 10.2174/1568008013341118.
Clinical presentation, diagnosis and treatment of vulvovaginitis in girls: a current approach and review of the literature.
Beyitler İ, Kavukcu S.
World J Pediatr. 2017 Apr;13(2):101-105. doi: 10.1007/s12519-016-0078-y. Epub 2016 Dec 15.
Chronic vulvitis in pre-pubertal girls.
Fischer G.
Australas J Dermatol. 2010 May;51(2):118-23. doi: 10.1111/j.1440-0960.2010.00631.x.
Efficacy, acceptability and tolerability of Zelesse for the treatment of non-specific vulvovaginitis in paediatric patients: The NINESSE Study.
García F, Rodríguez CA, Palomo ML, Català P, Fernández S, Huerta I, Velasco S, Nieto C; as the writing group of the NINESSE study.
J Int Med Res. 2018 Sep;46(9):3583-3595. doi: 10.1177/0300060518775566. Epub 2018 Jun 7.
Zoon's balanitis (balanitis circumscripta plasmacellularis).
Souteyrand P, Wong E, MacDonald DM.
Br J Dermatol. 1981 Aug;105(2):195-9. doi: 10.1111/j.1365-2133.1981.tb01205.x.
Vulvar dermatoses: a histopathologic review and classification of 183 cases.
Chan MP, Zimarowski MJ.
J Cutan Pathol. 2015 Aug;42(8):510-8. doi: 10.1111/cup.12541. Epub 2015 Jun 25.
How suitable are available pharmaceuticals for the treatment of sexually transmitted diseases? 1: Conditions presenting as genital discharges.
Willcox RR.
Br J Vener Dis. 1977 Oct;53(5):314-23. doi: 10.1136/sti.53.5.314.
